written by reader UNLOCKED: PRIVATE DEALS THAT MINT MILLIONAIRES

By xiexgp@gmail.com, August 18, 2014

August 15, 2014

Dear Reader,

Right now, a unique life-saving effort is underway in a sub-niche of the financial markets.

If you choose to invest in this ”campaign” – as I’ll outline in a moment – your reward will be twofold…

First, you’ll get the deep satisfaction of knowing your investment helped save lives – thousands – in the next 12 months alone.

Second, you’ll have an extraordinary opportunity to multiply every single dollar you invest mega-fold.

And that’s no exaggeration…

Imagine getting in on the next Facebook for 29 cents…

Or the next Google for 49 cents…

Or the next Apple for 39 cents…

That’s the nature of the opportunity at hand…

You see, this particular situation is unfolding in a niche legendary for creating millionaires.

In fact, in the last year alone – if you had gotten in on these companies when they were starting out – you could have seen gains of 1,000%… 1,100%… 2,000%… and 2,200%… all from this one lucrative sector.

And that’s only the tip of the iceberg…

Also in the last year, you could have cashed out mind-blowing gains of 8,500%… 14,000%…16,000% from this very same niche…

And, in one case, you could have seen a 120,000% gain.

That’s good enough to turn $1,000 into $1.2 million in one investment. Again, all of these gains are from one niche of the market.

Of course, these are exceptional cases. Not every play in this niche generated 10-fold gains, let alone 15,000% or even 120,000%.

As you’ll see in a moment, some only generated 300%. Others generated 700%. Some generated nothing at all.

The point is, if you get in early, and position yourself correctly, you could literally expand your net worth exponentially.

I’ll give you all the details in a moment. In fact, I’ll tell you all about a handful of tiny companies that have astronomical upside potential.

There is one small catch…

Ordinarily, the companies I’m going to tell you about aren’t available for public investment. In fact, most of them are PRIVATE. They’re tiny start-ups. The kind that savvy hedge fund managers would give their eyeteeth for… and simply can’t get in.

So the only way for YOU to get a stake in them at this ground-floor, pre-IPO stage… is to take advantage of a little-known backdoor I’ve uncovered.

And it’s so simple, anyone can do it, once you know how.

Bottom line: If you’d like to help save lives, while tapping into a niche that’s generated gains of 14,000%… 15,000%… 16,000%… and even 120,000%… then get ready… because in the next few minutes, I’ll tell you all about this opportunity.

In fact, I’ll detail a slew of tiny companies that you can get a piece of today.

These companies are all private. All ground-floor, pre-IPO opportunities. And you can essentially get a stake today for what comes to as little as 29 cents per share.

You may recall, Facebook went public at $38 per share. Imagine if you had gotten in on Facebook at 29 cents… You could have seen a 100-fold gain right out of the gate…

That’s the nature of the opportunity you have today. Let me tell you more…

It’s In Your Hands

My name, by the way, is Keith Fitz-Gerald…

If that rings a bell, it may be because I’m a frequent guest on CNBC World, Fox Business Network, Bloomberg, or CCTV.

Or maybe you’ve seen me quoted in Forbes, The Wall Street Journal, or Wired…

Or perhaps you read my bestselling book, Fiscal Hangover: How to Profit in the New Global Economy.

Or maybe you’ve seen one of the recommendations I’ve sent out over the last few years.

Hopefully, you’ve followed some of my ideas, because people who’ve listened to me have made a flat-out fortune.

Like Garrett Lawson, who sent me this note:

”I’ve profited in excess of $1.5 million.”

People like Phil Waters, who wrote to say:

”I’ve followed your recommendations and I’m up $45,000.”

Or Roger Murphy, who says:

”I’ve only been a member for about six months, and I’ve already made between $40,000 and $50,000. After 20 out of 20 wins, I became a lifetime member.”

Or Richard Padilla, who wrote me about his success:

”…an annualized return of +850%. Please find more of these recommendations!”

That’s what happens when folks start listening to me…

Now, I don’t tell you all this to brag… but I want to have your full attention. What I’m about to tell you deserves your full consideration.

Right now, I’m tracking what could be the most lucrative opportunity of my entire career.

Quite frankly, this is a rare and exceptional opportunity… a chance to impact your net worth in a profound way.

This opportunity is unfolding in a market niche that has the potential to mint new millionaires in a single transaction.

In the last year, you could have cashed in on opportunities that could have shown you 1,000%…. 2,200%… 14,000%… 15,000%… 16,000%… and even 120,000% since their inception.

Think about that. It’s good enough to turn $1,000 into $1.2 million…

As I mentioned, the companies I’m going to tell you about are private… and unavailable for public investment. But I’m going to show you how to get a stake in each of these companies for as little as 29 cents.

But the key is to grab a stake early, BEFORE the public floodgates open and drive these companies into orbit. Time is of the essence. So, let’s get right to it…

Private Deals That Mint Millionaires

Before we get to the specific companies, I want to make sure you understand just how lucrative a private deal can be.

I’m talking about getting in at the pre-IPO stage. This is pure ground floor; an opportunity most people NEVER get.

Typically, these opportunities are reserved for the big investment banks, venture capital firms, and angel investors with millions to invest.

By the time the general public gets a shot at these companies, the early-stage investors are already cashing out with monster wins.

Thing is, when these opportunities do arise, you gotta move fast.

And for those decisive folks with the guts to seize the moment… the rewards can be absolutely life altering.

Take Donald Chen…

Back in 2005, Chen was a down-on-his-luck artist. In fact, he was homeless, and even did jail time for forgery and stealing.

But one day, a unique opportunity presented itself… an opportunity that changed his life.

You see, the CEO of a tiny private company saw Chen’s art on the street, and asked if he would paint murals on the company’s office walls.

In exchange for his work, Chen was given a choice…

He could be paid in cash for his work…

Or he could be paid in the private company’s stock.

Chen needed cash badly… but he realized the private company was on the verge of hitting the big time… and he accepted the stock.

Savvy decision… because when the company went public… Chen made a staggering $200 million.

Remember: This company was private. The general public was not able to invest in it. But, Donald Chen recognized opportunity and was bold enough to seize it.

Today – right now – you have a very similar opportunity… a chance to grab a stake in a handful of tiny private companies that are poised to skyrocket, creating millionaires in the process.

I’ll tell you how to get in on these companies in a minute. But first, let me tell you about the remarkable things these companies are doing… and why they are ready to launch into orbit.

This Will Save Lives (and Make You Rich)

This first tiny company is almost completely unknown. But, it won’t be for long. In fact, in the coming months, you will likely be hearing about them on CNN and CNBC.

I believe Anderson Cooper will be praising them because of all the lives they are saving. And, Lou Dobbs will be talking about all the new millionaires they created.

You see, this tiny start-up – based in Santa Rosa, CA – has developed a breakthrough technology that will likely transform the medical world.

Every person on the planet – all 7.1 billion of us – is a potential customer for this technology.

Some will need it sooner. Some later. But regardless of who you are or where you live, chances are good you will need this yourself.

And here’s the thing: The alternative to buying this technology once you need it?

Death. It’s as simple as that…

In other words, this tiny company is poised to leverage a revolutionary life-saving technology into billions of dollars.

And even though this company is private, there’s a way for you to get a ground floor piece of the action. In fact, I’ll show you how to grab a stake for as little as 29 cents.

Imagine the money you could make when the company goes public… and your grubstake soars to $1… $5… even $12 per share.

And when you see what they’re doing, you’ll understand why this is absolutely possible.

”You’ve Got Two Months to Live”

What are the most vital organs in your body?

Your brain is one.

Your lungs are another.

And then there’s your heart…

Your heart starts beating before you are even born, and keeps working, nonstop, your entire life.

With the help of valves that open and close with every beat… your heart pumps blood throughout your body. It truly keeps you alive…

Now, the average human heart beats about 72 times per minute, and will beat roughly 2.5 billion times during your life.

Problem is, all that work takes a toll. And over time, the heart’s valves narrow.

This obstructs blood flow from your heart to the rest of your body, including your brain and lungs.

When the valve is obstructed, your heart must work harder to compensate for the faulty valve.

This weakens the heart and sets up potentially deadly consequences, including heart failure… cardiac arrest… blood clots… and stroke.

Bad news. In fact, without treatment, 80% of folks who develop symptoms of a faulty valve die…

80%!

And the scary thing is, this is a devastating diagnosis that could hit anyone…

And here’s the worst part: The solution can be more dangerous than the disease.

You see, traditionally, the only way to fix a faulty heart valve is open heart surgery.

A surgeon has to slice open your chest, crack open your ribs, and intentionally stop your heart in order to replace a faulty valve.

Risky business…

I mean, once your heart stops, there’s no guarantee it will start again. Plus, there is the risk of going under anesthesia for a lengthy surgery… not to mention the risk of infection.

In fact, the surgery is too dangerous for many older patients… the very folks who need it the most.

Sadly, they’re left to roll the dice… with an 80% chance of death…

That’s why this tiny start-up’s technology is such a revolutionary breakthrough…

Heart Valve Replacement – Without Surgery!

As amazing as it may sound, they’ve developed a way to replace faulty heart valves WITHOUT extensive surgery.

To say this is a life-saving innovation would be an understatement of epic proportions.

Instead of cracking open your chest and intentionally stopping your heart, the doctor simply inserts a tube, and wedges a new valve into place.

Minimal effort required! That means anyone who needs a new heart valve can get it, no matter their age or physical condition.

Analysts estimate the market for this technology is in the billions. Last year, the European Union approved this technology for sale in Europe.

And this tiny company just got FDA approval for tests in the United States.

Bottom line: This breakthrough technology is going worldwide.

And by the way, this company has not one… but 13 patents to protect their domain.

Make no mistake: This opportunity has homerun written all over it.

Listen, the biotech market is a breeding ground for new millionaires. In the last year alone, had you gotten in when these companies began, you could have cashed out with a slew of life-altering gains, including:

In addition, you could have cashed in on Amgen for a stunning 120,000%.

That’s a 1,200-fold gain. Good enough to turn $1,000 into $1.2 million in one play…

And get this: These are all gains you could have made AFTER the companies went public. Imagine how much you could have made if you’d gotten in while they were still private…

That’s virtually the exact situation you have today with the heart valve company I’ve been telling you about.

Make no mistake: This company has every bit the potential of the above winners…

Of course, the company is private. It’s not available to the public. But there is a way to grab a stake now, on the ground floor, for about 29 cents.

Let me show you how to do that now. This is actually a fascinating story… a story that could make you rich. Let me explain…

Reach Out and Take It!

Starting back in 1986, a small biotech start-up developed a series of drugs that have impacted the world and changed, among other things, the treatment of cancer.

This company’s technology and patents are among the most successful and profitable in the entire biotech industry. In fact, one of the drugs they developed literally starves cancer cells while leaving healthy cells alone. It’s truly incredible…

And here’s the twist…

Instead of selling the technology themselves… the company struck deals with the biggest players in the biotech market. Companies like Roche, Genentech, and Novartis.

This company does practically no work in producing or marketing these drugs. They sit back and let the big boys do the selling.

In return, they get an ongoing stream of fat royalties! As a result, they are raking in money hand over fist.

In fact, in 2013, international sales of the products they license topped $20 billion.

That’s $20 BILLION!

And get this: The company only has 10 employees with 2013 total expenses of only $35 million.

Think about that. It’s unheard of! And the profits are staggering…

And herein lies a remarkable opportunity for you…

You see, instead of sitting on their cash… this company is turning around… and investing in the very thing they know best:

That’s right: Small biotech start-ups…

In essence, they have become like a private equity firm with the potential to make you an absolute fortune.

You see, these guys are experts… a team of doctors, scientists, and researchers – medical geniuses!

And they’ve been in the business for over 30 years.

They know the biotech market like the back of their hand. Consequently, they are perfectly positioned to spot biotech start-ups on the brink of explosive growth.

By investing in these start-ups, like the heart valve company I told you about earlier, this outfit is getting in at the ground-floor, pre-IPO stage.

And their investment strategy is about as brilliant as it gets. You see, this company identifies late-stage, tiny biotech companies… companies that already have a proven product with patent protection.

Typically, these tiny firms need a last blast of financing to put them over the top and into the big time.

That’s exactly what this ”private equity” firm provides…

In essence, they are investing at the best possible time: AFTER all the research and development has been successfully completed…

But BEFORE the private firms they work with go public and launch into the stratosphere.

In return for their investment, they get partial control of patents… royalties from products… and huge interest payments in the neighborhood of 15% or higher.

Of course, the big thing they get is access to an enormous upside. Again, the biotech market has spawned countless millionaires.

And here’s the thing: While most of the companies they invest in are private… the ”private equity” company is public.

By owning a stake in this ”private equity” company, you are getting a piece of every single private deal they are involved in.

For example, this company is financing the heart-valve start-up I told you about earlier.

Remember, the heart-valve start-up’s life-saving technology is on the brink of becoming a household name. And by investing in the ”private equity” company, you’re essentially grabbing a stake in it for roughly 29 cents!

That’s because when you factor in the ”private equity” company’s share price, their market cap, and the amount they’ve invested in the heart-valve company… we estimate you’re grabbing a stake in the heart-valve company for a mere 29 cents per share.

The upside is enormous. And the heart-valve company is only the beginning…

Several thousand exciting little biotech companies are coming up fast in the investment world right now.

Many have staggering potential both in terms of the products they will develop and the fortunes they will generate.

And almost every single one of them is private and off limits…

But by tapping into this backdoor play, you can get a piece of the action. Here’s a small taste of the companies you can get in on:

Back Pain: A Thing of the Past! Right now, over 600,000 people in America alone undergo painful fusion surgery annually. It’s a rough surgery, with a long, painful recovery. Unfortunately, it’s often the only option. Until now. A tiny California start-up has developed a device that relieves spinal stenosis without fusion surgery. This start-up has created a device that is the first and only of its kind. It offers an effective, lasting alternative to painful fusion surgery. Not only is it patented… but it has already received FDA approval. The start-up is positioned to dominate a $17 billion market… expanding their value mega-fold. Bottom line: This start-up is primed and ready for an explosive bolt upward. Of course, they aren’t available for public investment. But you can grab a stake for roughly 49 cents!

Killing the Superbug! Health officials have been warning us for 30 years about drug-resistant superbugs. But now, the problem has become epidemic. In fact, the CDC estimates that more than 2 million people get superbugs each year, and at least 23,000 die because current drugs no longer stop their infections. That’s almost three deaths every single hour from superbugs! Fortunately, a tiny start-up in Chicago has developed a ”super drug” designed to wipe out superbugs. It’s the first and only drug of its kind. It’s been granted four patents… and on May 23, 2014, it was granted FDA approval. This tiny company is a certain lifesaver. It’s also a potential rocketship headed into the stratosphere… and you can own it today!

Breakthrough Nerve Repair Halts Amputation! Talk about a miracle. A tiny company in Florida has developed a technology to regenerate severed nerves so patients can avoid amputation. Amazing! In fact, recently, a bullet ripped through Navy Corpsman Ed Banner’s left leg while he was on patrol in Afghanistan. Until now, the only choice would have been amputation. But, thanks to this tiny company, Banner’s nerve was repaired and he is walking again! And that’s good news for the 300,000 Americans who suffer severe nerve injuries every year. This company has multiple patents on this technology… and stands to make early investors a fortune. Today, you can get in on the ground floor!

I think you’ll agree: Each of these companies offer amazing technologies that are changing – and saving – lives.

They also will likely mint a slew of new millionaires in the coming months and years.

And guess what? These companies are only the tip of the iceberg!

By investing in this ”private equity” firm today, you can indirectly access the hottest deals in the biotech market, including:
•A tiny company that is revolutionizing the treatment of cataracts… an eye condition that affects over 20 million Americans…

•A small start-up that has developed a FDA-approved system to treat life-threatening allergic reactions…

•A private company that has developed a device that fights artery disease and helps patients keep their legs… without major surgery!

Again, these companies are on the cutting edge of the biotech market…

And that’s no small thing…

Remember, the biotech market has already created massive wealth. In the last year, you could have cashed out with a slew of life-altering gains, including: 300%… 700%… 1,000%… 1,100%… 2,000%… 2,200%… 14,000%… 15,000%… and 16,000%…

In addition, you could have cashed in on Amgen for a stunning 120,000%.

That’s a 1,200-fold gain. Good enough to turn $1,000 into $1.2 million in one play…

And here’s the kicker…

They’ll Pay You 7%!

That’s right. This ”private equity” company is hauling in so much cash, that even after investing, it’s got piles of money left over.

Remember: Total sales of the products they received royalties on in 2013 exceeded $20 billion, paying them a healthy $443 million in revenue… while their expenses were a mere $35 million.

The royalties they collect are off the charts. And because they want their shareholders to participate in their riches… they are paying a quarterly dividend of 7%.

That means you earn a fat 7% on every penny you invest… while gaining access to some of the hottest deals in the biotech market.

This opportunity is a no-brainer and I urge you to move on it today.

Remember, opportunities like this are rare… and any one of these private companies are poised to explode into the mainstream.

You need to get in now, while each of these is still a ground floor play.

I’ve put all the details on this biotech backdoor in a special report called Private Biotech Deals That Mint Millionaires! The report will tell you the name of the company, its stock symbol, and a way for you to buy in for a fraction of what its value will be in the future.

The report is yours free. Let me show you how to get your copy today…

Don’t Get Left Behind!

Go ahead and give my monthly newsletter, Money Map Report, a risk-free try.

The moment you agree to try us out, you’ll get access to my special report Private Biotech Deals That Mint Millionaires!

The report will tell you everything you need to know about the biotech opportunities I’ve detailed in this presentation.

I think you’ll discover very quickly, Money Map Report is an indispensable financial resource you can’t afford to be without.

In fact, financial superstars such as Peter Schiff, Dr. Mark Skousen, Jon Markman, and Paul Forchione have praised my work.

As Dr. Mark Skousen said, ”If you don’t follow his advice, you will be left behind.”

I’ve been called ”The Indiana Jones of Investing.”

Why? Because I’m constantly traveling around the globe in search of those hard-to-find places where…

Extravagant government spending…

Loose-money policies of central banks…

And the ”smart money” of private investors…

Have COME TOGETHER…

To create a situation where money is virtually falling from the sky. This usually translates into big winners for my readers across the board, including:

And I’m not even going to bother telling you about the literally dozens upon dozens of double-digit gainers we’ve recommended, some as high as 51% and 99%…

As you can imagine, folks who follow my recommendations are thrilled. Let me remind you what a few of them are saying:

”I’ve profited in excess of $1.5 million.” – Garrett Lawson

”I’ve followed your recommendations and I’m up $45,000.” – Phil Waters

”I’ve already made between $40,000 and $50,000.” – Roger Murphy

”…an annualized return of +850%. Please find more of these recommendations!”
– Richard Padilla

I’ve got an inbox full of rave reviews just like these…

But listen: As proud as I am of these winners, I must tell you they pale in comparison to the potential you have with the biotech opportunity I’ve been telling you about.

Not only does it give you backdoor access to the hottest deals in the biotech sector, opportunities that could multiply every dollar you invest mega-fold…

But, you also earn a fat 7% on every penny you invest… paid out like clockwork!

It doesn’t get better than that. And this biotech opportunity is only the beginning. As a member of Money Map Report, you’ll get a slew of exclusive benefits, including:
1.FREE WEEKLY EDITIONS OF THE MONEY MAP REPORTER: Direct from my keyboard to your inbox, I’ll send you a weekly update on all the positions in our recommended portfolio and let you know when to make a move and when to sit tight…

2.FREE EMAIL ALERTS AND RECOMMENDATIONS: If there’s an opportunity developing in the market that can’t wait until the next issue of Money Map Report, I’ll fire off an email to you as soon as I find out about it…

3.FREE SAFETY SWITCHES: The same goes for investments that are ripe for plucking. When it’s time to exit a position, I’ll immediately let you know when and how to do it…

4.FREE INVESTOR BRIEFINGS: I’ll discuss new global trends I’ve identified and how you can put yourself in the right place at the right time to take full advantage of them…

5.FREE 24/7 ACCESS TO THE MONEY MAP REPORT WEB PORTAL! Your members-only website that gives unlimited, free access to every issue of the Money Map Report, plus every alert, recommendation, and briefing…

6.FREE ”BOOTS ON THE GROUND” REPORTS FROM AROUND THE WORLD!

How much does all this cost? That’s the best part…

You’ve already seen the rave reviews from my readers. And I can tell you right now, these folks gladly pay $199 for a full year of information, research advice, and guidance that’s not available anywhere else at any price…

That’s less than the cost of a good pair of running shoes nowadays…

Yet you’ll even pay less! (More about that in a moment.)

But first, let me tell you about something else I want you to have as a member of the Money Map Report…

A Massive (and Lucrative) Dose of Government Spending

An in-depth review of recent legislation reveals an exciting opportunity that could make you a pile of money.

In fact, a close look at recent laws indicates that the federal government is poised to enter into contracts with private companies to buy vaccines…

Not only does legislation suggest the government will be buying more vaccines… but it will also be promoting their benefits…

Organizing the inoculation of millions of Americans with vaccines…

And encouraging state governments to do the same…

To put this in street language, the U.S. Government is about to become the world’s biggest ”pusher” of vaccines!

In other words, the vaccine business…

Which used to be a slow-moving ”backwater” of the pharmaceutical industry…

Is about to shoot up like a geyser…

Some analysts say the vaccine market could expand by 15% a year for the foreseeable future…

According to the World Health Organization, the vaccine market could be worth $100 billion by 2025…

Or four times what it is today!

So, how can YOU make money on this?

Well, you could buy GlaxoSmithKline (GSK), which is the market leader in vaccines with 23% global market share…

Unfortunately, at roughly $50 a share for GSK, the potential for growth is limited…

But what if I told you there was another stock that’s currently selling around $10 a share… a small, undiscovered company with a tiny market cap of a mere $600 million…

To put that in perspective, GlaxoSmithKline has a market cap of $130 billion!

It’s 220 times bigger…

Think about the potential upside… it’s mind-boggling…

The incredible thing is this company actually MAKES their own vaccines in the laboratory by synthesizing them out of DNA…

So, theoretically, they can attack virtually ANY infectious disease around the world…

From AIDS… to bird flu… to typhoid… you name it!

Buy 1,000 shares of this company and you’ll pay roughly $10,000…

But if exploding global demand for vaccines causes it to rise… you could have $20,000… $50,000… $150,000… $250,000 or more!

It will be like standing in front of a FIRE HOSE spraying hundred dollar bills…

And you could have that fire hose aimed right at your wallet if you invest in this stock and the three other vaccine stocks I’ll tell you about in your copy of…

Ride the Global Vaccine Explosion for Mega-Gains!

The report is yours, FREE, just for giving Money Map Report a risk-free try. I’ll tell you how to do that in just a few moments…

But first let me give you a peek at the bigger picture…

You see, opportunities like this are everywhere… and when you know how to spot them, you can make an absolute fortune from trends that most people have no clue about.

That brings us to another free gift I’d like you to have, just for giving Money Map Report a risk-free try…

Revealed: The Money Map Method!

It’s tough out there for investors. Quite frankly, the world of investing has changed…

The old investment strategies have gone the way of the gold watch, the dependable pension plan, and tax-free muni bonds that pay 5% a year…

Today, we’re in an era of ZERO interest rates… NEGLIGIBLE growth… and MASSIVE government spending…

How do you make a profit in this environment?

How do you find the opportunities to make money in this new globalized and government-manipulated economy…

And, trust me, there ARE opportunities…

No scratch that. There are actually MORE opportunities available to investors today than there were in the last century…

But how do you SPOT them?

That’s where the Money Map Method comes in…

The Money Map Method is a unique system for tracking the movement of enormous sums of money…

Government spending…

Central bank cash…

And large private investments…

Wherever they flow around the world…

Remember when ”Deep Throat” told Woodward and Bernstein that the key to solving the mystery of Watergate was to…

”FOLLOW THE MONEY!”

Well, that’s what the Money Map Method does…

Only we don’t just follow the money. Our analysts find out where the smart money is going before it gets there…

So you’re in a perfect position to profit when the money starts falling…

Does the Money Map Method work? You better believe it…

In fact, we backtested the Money Map Method against the S&P 500 Index Fund over a 12-year period…

Not just ANY 12-year period…

We chose the twelve years between 2000 and 2012…

Because they were among the most turbulent years in the history of the stock market…

During this period, there were two costly wars…

Two major recessions…

The dot.com stock market crash of 2000…

The fiscal crash of 2008…

And no fewer than THREE investment ”bubbles” when some stocks grew well beyond their actual value…

Then came plummeting back to earth…

No wonder the S&P index posted a lousy 10.7% – over 12 full years!

But guess what…

The Money Map Method would have actually GAINED 270% in value over the same period…

And this was achieved by using a specially concentrated combination of investments that gave you much more upside than the broadly-diversified S&P 500 index fund…

That’s why the Money Map Method is such a powerful tool for making money…

Because I want you to understand and utilize this powerful system yourself, I’ve put all the secrets into a FREE BOOK which I’d like to send you today. It’s called…

THE MONEY MAP METHOD: Lifelong Wealth in a Forever-Changed World.

This 77-page book is yours to keep absolutely free… just for giving Money Map Report a risk-free try.

All you need do is hit the button at the bottom of the page. The moment you join, you’ll have access to three powerful moneymaking resources, including:
•Free Gift #1: Private Biotech Deals That Mint Millionaires!

•Free Gift #2: Ride the Global Vaccine Explosion for Mega Gains!

•Free Gift #3: THE MONEY MAP METHOD: Lifelong Wealth in a Forever-Changed World.

Add it all up, and I think you’ll agree that a subscription to the Money Map Report is a bargain at $199, but…

Because I want everyone to take advantage of the incredible opportunities I’ve described here…

I’ve decided to cut the price of the Money Map Report in HALF.

Instead of paying $199 for the next 12 issues of the Money Map Report – and all the freebies, bonuses, and benefits I’ve just described – you’ll pay only…

$49.50!

That’s actually MORE than half off – a savings of 75% – for as long as our supplies of these important resources last…

And listen, because I want to make this an absolute no-brainer for you, let me give you my personal pledge and guarantee:

Go ahead and try the first 3 ISSUES of the Money Map Report on a completely risk-free basis…

Read the first three issues of the Money Map Report without any risk or obligation…

Take full advantage of my weekly bulletin, the Money Map Reporter…

Get the FREE email alerts… FREE safety switches… FREE investor briefings… and my FREE ”boots-on-the-ground” reports from around the globe…

In other words, take full advantage of the Money Map Method for THREE FULL MONTHS…

And if, by any chance, it doesn’t help you…

Simply let me know and I’ll send you…

ALL OF YOUR MONEY BACK!

Not a pro-rated refund. Not a refund on unmailed issues. Not a conditional refund of any kind…

But an unconditional, no-questions-asked, 100% refund on every penny you paid…

Even better, you can keep everything I send you.

So please take a moment right now to click here and view our secure order form…

Clicking commits you to nothing…

You can always change your mind at any time…

But you must act fast. You see, the biotech opportunities I’ve described here are on the verge of becoming household names.

You absolutely must get in before they go public if you want the best chance for success.

After that, the big gains will ALREADY be gone…

They’ll be scooped up by the investors who got there first…

That’s why it’s URGENT that you click here now…

It will take you to a secure order form…

And that form will tell you exactly how to get your…

FREE copy of Private Biotech Deals That Mint Millionaires!

FREE copy of my special report Ride the Global Vaccine Explosion for Mega Gains!

And FREE copy of my strategic manifesto, THE MONEY MAP METHOD…

All of that just for taking a risk-free look at the Money Map Report for 3 FULL MONTHS without obligation or commitment…

When you elect to proceed to the order form…

You’ll have a chance to review everything before making a final decision and submitting your order…

So please click here or on the button below right now…

Or if you’d prefer to sign up by phone…

Simply call 1.866.460.9039 or 1.443.353.4384 (for international callers) from 9 am to 5 pm (Eastern Time) – and be sure to mention Priority Code EMMRQ805.

The clock is ticking… so do it now. You’ll be so glad you did…

Sincerely,

Keith Fitz-Gerald
Chief Investment Strategist, Money Map Report
July 2014

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

6 Comments
Inline Feedbacks
View all comments
newbie
Irregular
newbie
August 18, 2014 2:08 pm

Hi Travis,
can you please put this ad to your mighty “thinkolator” to decipher the hyped private equity
company?
Many thanks in advance!

newbie

irsh
August 18, 2014 4:10 pm

Travis, this does sound a little tantalizing! Penney for your thoughts!!!

Donna
Member
Donna
August 18, 2014 6:45 pm
Reply to  irsh

Travis,
I agree with irsh. I would like to hear what the thinkolator has to say about this one.
I have been researching but I have come up empty.

advantedges
Irregular
advantedges
February 5, 2015 2:57 am
Reply to  Donna

Travis. Obviously several of us would like to uncover the investment teased by Fitz-Gerald.
Can you clue us in?

👍 112
dsantoro
Member
dsantoro
July 4, 2015 2:21 pm

That was August of 2014. Here I am in June, 2015, more than a year ago and clueless. Was an answer posted?

👍 6
cnburton
Irregular
cnburton
July 26, 2015 5:55 pm

I came here looking for the answer as well. I think it is Medtronic. Here is there 2013 press release lead: Medtronic, Inc. (NYSE: MDT) today announced it has received Conformité Européenne (CE) Mark for valve-in-valve (VIV) procedures using the CoreValve® and CoreValve® Evolut(TM) transcatheter aortic valve implantation (TAVI) systems in degenerated bioprosthetic surgical aortic valves. This is the first ever regulatory approval for VIV procedures, which provide a minimally invasive treatment option for patients whose surgical aortic valves have degenerated, and who are at extreme or high risk for surgery and would otherwise go untreated. The CoreValve VIV procedures are not approved in the United States.

Add a Topic
6225